
It’s been an exciting month of launches for the Blanchard Lab! 🚀 Alongside launching our #miBrains into space, I’m excited to share the launch of our brand new lab website! Take a look 👇 joelblanchardlab.com

senior media relations manager @ Stellate Communications

It’s been an exciting month of launches for the Blanchard Lab! 🚀 Alongside launching our #miBrains into space, I’m excited to share the launch of our brand new lab website! Take a look 👇 joelblanchardlab.com

This week we’re at @NASAKennedy preparing human brain tissue models for space, just in time for #WorldSpaceWeek! 🚀 Follow along to see how microgravity & radiation affect interactions across 6 brain cell types, with insights for astronauts and for neurodegeneration on Earth.

Stellate is a 2026 Top Agency! 🎉 @PRDaily's Top Agencies Award is the industry's most competitive recognition program, honoring the agencies & workplaces shaping where public relations & communications are headed next. See the entire list: ragan.com/awards/events/top-…

Blood vessels in the brain deteriorate in Alzheimer’s, especially in APOE4 carriers. But what drives this damage? Our new study, out now in @CellPressNews , uncovers a mechanism linking APOE4 to vascular fibrosis and amyloid accumulation in the brain. 🧠🧬

Funding call is out from Intercept, tech-funded effort to prevent respiratory viruses. Goal: an invention that will stop 75% of infection w/ path to >60% uptake in population. Ha ha. I think it's called "masks." But they are def interested in drugs. interceptfund.com/apply/broa…
An aseptic ambition? Stripe, Anthropic, OpenAI Foundation fund $500 million effort to stop the common cold--plus other respiratory infections. technologyreview.com/2026/06…

Has AI been a net positive or negative for survey research? In episode 1 of The Signal, Dr. David Rothschild (@MSFTResearch, @AAPOR AI task force Co-chair) joins @andrew_j_gordon on where AI helps, where synthetic data breaks down, and why transparency beats standards.

The human brain is largely inaccessible as diseases like Alzheimer’s and Parkinson’s develop, limiting our ability to understand the mechanisms that drive neurodegeneration. To address this challenge, we created a multicellular integrated brain tissue, or #miBrain 🧠

Using a multicellular human brain model, our latest study, now published in @CellStemCell, identifies APOE4 astrocytes as key drivers of α-synuclein pathology, uncovering a new mechanism linking genetic risk to neurodegeneration. cell.com/cell-stem-cell/full…

New website for the @SuthanaLab at Duke. Neuroscience in motion — built by @stellatecomms to match the ambition of the science. suthanalab.com stellatecomms.com/creative-p…

The 2026 Virtual Cell Challenge has begun! Submissions and the leaderboard are now open. This year's task: multi-context generalization and zero-shot prediction. Models will need to predict perturbation responses in cellular contexts with no Challenge-specific training data. arcinstitute.org/news/virtua…

Excited to share our new preprint identifying THAP12 as the first transcriptional regulator of mitochondrial ETC Complex I and expanding the diseases that may benefit from hypoxia therapy. Led by the amazing Brandon Desousa and coadvised by @KampmannLab biorxiv.org/content/10.64898…
Complex I is the largest complex of the electron transport chain and the entry point for electrons that power ATP production. New work from Core Investigator @ishahjain and team identifies THAP12 as a dedicated transcription factor controlling how much Complex I a cell builds.

Brain-computer interfaces implanted long term could help researchers unravel the mysteries of speech. By @claulopezneuro thetransmitter.org/brain-com…

Start assembling your team because the 2026 Virtual Cell Challenge officially kicks off on Thursday, August 20. This is round two of our global competition to understand and predict how cells respond to internal cues and external stimuli. Expect a new problem to solve, a wider range of metrics, and a $100,000 grand prize. We look forward to sharing more details at launch.

The project is “aimed at making respiratory infections like the common cold and flu a thing of the past” time.com/article/2026/06/24/…

People spend ~5% of their lives sick the with cold & flu. Intercept — a $500M philanthropic initiative spearheaded by @stripe — aims to make respiratory infections a thing of the past. We're proud to have helped usher Intercept into the world today 🚀 interceptfund.com/

Intercept, a new nonprofit, will focus on countering the common cold and the flu. trib.al/WIGGohZ